OMRF researchers uncover a genetic link between lymphatic valve formation and Crohn's disease, paving the way for future treatments.

Physicians treating patients with Crohn's disease face a plethora of drug choices. Yet, overall rates of clinical response seem stable over time,1 suggesting the existence of a therapeutic ceiling ...

About 3.1 million adults in the United States have inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis (UC). But just as each person is unique, so is their ...

Bhat: From a medication standpoint, there is still much to uncover regarding why treatments vary in effectiveness among ...

Bhat: I love this question! Crohn’s disease treatment has progressed significantly in recent years, incorporating new ...

In a European study, higher consumption of fruits, vegetables, legumes, and potatoes was associated with a reduced risk of ...

1 Introduction The incidence of pediatric Crohn’s disease (CD) has increased rapidly over the past decades (Kuenzig et al., 2022). During this same period, anti-tumor necrosis factor (TNF) has become ...

Introduction Adalimumab is effective for maintenance of remission in patients with Crohn’s disease (CD) at a dose of 40 mg subcutaneously every 2 weeks. However, adalimumab is associated with ...

Background/Aim: Immunosuppressants are now used much earlier in the course of Crohn’s disease; however their effect on the natural history of the disease, especially on the need for surgery, is not ...